• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

2012 - 2022年伊拉克女性乳腺癌和卵巢癌的发病趋势及其与生育模式的关系

Breast and Ovarian Cancers' Incidence Trends Among Iraqi Women During 2012-2022 and Their Relationship to Fertility Patterns.

作者信息

Naeem Al-Asadi Jasim

机构信息

College of Pharmacy, University of Manara, Misan, Iraq.

出版信息

Sultan Qaboos Univ Med J. 2025 May 2;25(1):499-505. doi: 10.18295/2075-0528.2863. eCollection 2025.

DOI:10.18295/2075-0528.2863
PMID:40657466
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC12255333/
Abstract

OBJECTIVES

This study aimed to estimate the incidence trends of female breast cancer (BC) and ovarian cancer (OC) among women in Iraq and their relation to fertility patterns.

METHODS

This retrospective study utilised the Iraqi Cancer Registry annual reports for the years 2012-2022 and the World Bank data for Iraqi crude birth rate and total fertility data for the years 1992-2002. Simple linear regression analysis examined the relationship between these variables and incidence rates of BC and OC.

RESULTS

A total of 63,446 women were newly diagnosed with BC from 2012-2022. The overall age standardised incidence rate (ASIR) of BC was 46.68/100,000 females. It increased significantly from 36.61/100,000 in 2012 to 61.89/100,000 in 2022 with an average annual percentage change (AAPC) of 4.83% (95% confidence interval [CI]: 2.69-7.08; < 0.001). The overall ASIR rate of OC was 6.22/100,000 women. It increased significantly from 4.35/100,000 in 2012 to 6.90/100,000 in 2022 with an AAPC of 4.58% (95% CI: 2.40-6.88; < 0.001). The ASIR of BC was negatively and significantly associated with crude birth rate (CBR) and total fertility (TFR) rate (R = 0.727; = 0.001 and R = 0.728; = 0.001, respectively). The ASIR of OC was negatively and significantly associated with CBR and TFR (R = 0.699; = 0.001 and R = 0.696; = 0.001, respectively).

CONCLUSIONS

Iraqi women are experiencing a rising incidence of breast and ovarian cancers over time. Lower fertility rates may partly play a role in this trend. Research and initiatives are necessary to identify and control the factors that are increasing this risk.

摘要

目的

本研究旨在估计伊拉克女性乳腺癌(BC)和卵巢癌(OC)的发病趋势及其与生育模式的关系。

方法

这项回顾性研究利用了伊拉克癌症登记处2012 - 2022年的年度报告以及世界银行提供的1992 - 2002年伊拉克粗出生率和总生育率数据。简单线性回归分析检验了这些变量与BC和OC发病率之间的关系。

结果

2012 - 2022年共有63446名女性被新诊断为BC。BC的总体年龄标准化发病率(ASIR)为46.68/10万女性。它从2012年的36.61/10万显著增加到2022年的61.89/10万,平均年百分比变化(AAPC)为4.83%(95%置信区间[CI]:2.69 - 7.08;P < 0.001)。OC的总体ASIR为6.22/10万女性。它从2012年的4.35/10万显著增加到2022年的6.90/10万,AAPC为4.58%(95% CI:2.40 - 6.88;P < 0.001)。BC的ASIR与粗出生率(CBR)和总生育率(TFR)呈显著负相关(R分别为0.727;P = 0.001和R为0.728;P = 0.001)。OC的ASIR与CBR和TFR呈显著负相关(R分别为0.699;P = 0.001和R为0.696;P = 0.001)。

结论

随着时间的推移,伊拉克女性乳腺癌和卵巢癌的发病率呈上升趋势。较低的生育率可能在这一趋势中起到了一定作用。有必要开展研究和采取措施来识别和控制增加这种风险的因素。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/769a/12255333/7d68e217250c/squmj_v25_n01_squmj6932-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/769a/12255333/399acfa68b28/squmj_v25_n01_squmj6932-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/769a/12255333/e06799e7847c/squmj_v25_n01_squmj6932-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/769a/12255333/f76e6db823c4/squmj_v25_n01_squmj6932-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/769a/12255333/7d68e217250c/squmj_v25_n01_squmj6932-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/769a/12255333/399acfa68b28/squmj_v25_n01_squmj6932-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/769a/12255333/e06799e7847c/squmj_v25_n01_squmj6932-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/769a/12255333/f76e6db823c4/squmj_v25_n01_squmj6932-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/769a/12255333/7d68e217250c/squmj_v25_n01_squmj6932-g004.jpg

相似文献

1
Breast and Ovarian Cancers' Incidence Trends Among Iraqi Women During 2012-2022 and Their Relationship to Fertility Patterns.2012 - 2022年伊拉克女性乳腺癌和卵巢癌的发病趋势及其与生育模式的关系
Sultan Qaboos Univ Med J. 2025 May 2;25(1):499-505. doi: 10.18295/2075-0528.2863. eCollection 2025.
2
Interventions for fertility preservation in women with cancer undergoing chemotherapy.对接受化疗的癌症女性进行生育力保存的干预措施。
Cochrane Database Syst Rev. 2025 Jun 19;6:CD012891. doi: 10.1002/14651858.CD012891.pub2.
3
Antioxidants for female subfertility.用于女性生育力低下的抗氧化剂。
Cochrane Database Syst Rev. 2017 Jul 28;7(7):CD007807. doi: 10.1002/14651858.CD007807.pub3.
4
Risk-reducing bilateral salpingo-oophorectomy in women with BRCA1 or BRCA2 mutations.对携带BRCA1或BRCA2基因突变的女性进行降低风险的双侧输卵管卵巢切除术。
Cochrane Database Syst Rev. 2018 Aug 24;8(8):CD012464. doi: 10.1002/14651858.CD012464.pub2.
5
Fertility preservation in young patients with breast cancer: insights from the Gemme Dormienti network.年轻乳腺癌患者的生育力保存:来自Gemme Dormienti网络的见解
Ther Adv Med Oncol. 2025 Jul 13;17:17588359251341210. doi: 10.1177/17588359251341210. eCollection 2025.
6
Antioxidants for female subfertility.用于女性生育力低下的抗氧化剂。
Cochrane Database Syst Rev. 2013 Aug 5(8):CD007807. doi: 10.1002/14651858.CD007807.pub2.
7
A rapid and systematic review of the clinical effectiveness and cost-effectiveness of topotecan for ovarian cancer.拓扑替康治疗卵巢癌的临床有效性和成本效益的快速系统评价。
Health Technol Assess. 2001;5(28):1-110. doi: 10.3310/hta5280.
8
Risk of ovarian cancer in women treated with ovarian stimulating drugs for infertility.接受卵巢刺激药物治疗不孕症的女性患卵巢癌的风险。
Cochrane Database Syst Rev. 2013 Aug 13;2013(8):CD008215. doi: 10.1002/14651858.CD008215.pub2.
9
Taxane monotherapy regimens for the treatment of recurrent epithelial ovarian cancer.紫杉烷类单药治疗方案用于复发性上皮性卵巢癌。
Cochrane Database Syst Rev. 2022 Jul 12;7(7):CD008766. doi: 10.1002/14651858.CD008766.pub3.
10
Oral medications including clomiphene citrate or aromatase inhibitors with gonadotropins for controlled ovarian stimulation in women undergoing in vitro fertilisation.口服药物,包括枸橼酸氯米芬或芳香化酶抑制剂与促性腺激素联合用于接受体外受精的女性的控制性卵巢刺激。
Cochrane Database Syst Rev. 2017 Nov 2;11(11):CD008528. doi: 10.1002/14651858.CD008528.pub3.

本文引用的文献

1
Global cancer statistics 2022: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries.2022 年全球癌症统计数据:全球 185 个国家和地区 36 种癌症的发病率和死亡率全球估计数。
CA Cancer J Clin. 2024 May-Jun;74(3):229-263. doi: 10.3322/caac.21834. Epub 2024 Apr 4.
2
Cancer statistics, 2023.癌症统计数据,2023 年。
CA Cancer J Clin. 2023 Jan;73(1):17-48. doi: 10.3322/caac.21763.
3
Ovarian cancer in Lebanese women: a 12-year comparative epidemiological study and trend analysis.黎巴嫩女性卵巢癌:一项为期12年的比较流行病学研究及趋势分析。
Ecancermedicalscience. 2022 Jun 13;16:1409. doi: 10.3332/ecancer.2022.1409. eCollection 2022.
4
Understanding How Pregnancy Protects Against Ovarian and Endometrial Cancer Development: Fetal Antigens May Be Involved.了解妊娠如何预防卵巢和子宫内膜癌的发生:可能涉及胎儿抗原。
Endocrinology. 2022 Oct 11;163(11). doi: 10.1210/endocr/bqac141.
5
Pregnancy duration and ovarian cancer risk: A 50-year nationwide cohort study.妊娠持续时间与卵巢癌风险:一项长达 50 年的全国性队列研究。
Int J Cancer. 2022 Nov 15;151(10):1717-1725. doi: 10.1002/ijc.34192. Epub 2022 Jul 12.
6
Worldwide Burden, Risk Factors, and Temporal Trends of Ovarian Cancer: A Global Study.全球卵巢癌负担、风险因素及时间趋势:一项全球研究。
Cancers (Basel). 2022 Apr 29;14(9):2230. doi: 10.3390/cancers14092230.
7
Trends in Breast Cancer Incidence in Iraq During the Period 2000-2019.2000-2019 年期间伊拉克乳腺癌发病率趋势。
Asian Pac J Cancer Prev. 2021 Dec 1;22(12):3889-3896. doi: 10.31557/APJCP.2021.22.12.3889.
8
Reproductive Pattern of Parous Women and the Risk of Cancer in Later Life.经产妇的生殖模式与晚年患癌风险
Cancers (Basel). 2021 Jul 24;13(15):3731. doi: 10.3390/cancers13153731.
9
Reproductive Factors and Breast Cancer Risk in Lithuanian Women: A Population-Based Cohort Study.立陶宛女性的生殖因素与乳腺癌风险:一项基于人群的队列研究。
Acta Med Litu. 2020;27(2):70-75. doi: 10.15388/Amed.2020.27.2.4. Epub 2020 Dec 21.
10
The Global, Regional, and National Burden and Trends of Breast Cancer From 1990 to 2019: Results From the Global Burden of Disease Study 2019.1990年至2019年全球、区域和国家乳腺癌负担及趋势:全球疾病负担研究2019结果
Front Oncol. 2021 May 21;11:689562. doi: 10.3389/fonc.2021.689562. eCollection 2021.